Hill-Rom reports strong financial results for third quarter of 2015

Hill-Rom has announced its financial results for the third quarter of its 2015 fiscal year, during which it achieved strong double-digit growth.

The company's quarterly revenue total came to $475 million (304.74 million pounds), which represented a year-on-year increase of 19 percent, or 26 percent on a constant currency basis.

This strong momentum was primarily due to the Trumpf Medical acquisition and strong North America capital revenue growth. Its adjusted earnings per diluted share of $0.62 rose five percent from the prior year.

Moreover, the firm was able to accelerate its growth strategy with an agreement to acquire Welch Allyn in a deal worth $2.05 billion.

John Greisch, Hill-Rom president and chief executive officer, said: "We are confident that our combination with Welch Allyn will advance our strategic objectives and create a stronger platform from which to deliver increased shareholder value."

The company now expects its full-year adjusted earnings per diluted share to be in the range of $2.51 to $2.54, compared to $2.50 to $2.54 previously.